US 12060396
Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis
granted A61KA61K38/00A61K38/1709
Quick answer
US patent 12060396 (Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis) held by THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
- Grant date
- Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61K38/1709, A61K38/1777, A61K38/1825